InMed Pharmaceuticals Inc. (INM) reports FY EPS of ($3.25)

InMed Pharmaceuticals Inc. (NASDAQ: INM) reported FY EPS of ($3.25). Revenue for the FY came in at $4.14 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Movano (MOVE) Misses Q2 EPS by 195c